Skip to product information
1 of 1
Home Product TRAcP Control Slides

BSB-9417-CS | TRAcP Control Slides

US
IVD, RUO
Europe
RUO
International
IVD, RUO
Contact for price View full details

Product Information

Summary & Explanation

{"type":"root","children":[{"type":"paragraph","children":[{"type":"text","value":"Tartrate-resistant acid phosphatase (TRAcP) is a glycosylated monomeric metallo-enzyme expressed in mammals. It has a molecular weight of approximately 35 kDa, a basic isoelectric point (7.6 - 9.5), and optimal activity in acidic conditions. TRAcP is synthesized as a latent proenzyme and is activated by proteolytic cleavage and reduction. Normally, TRAcP is highly expressed by osteoclasts, activated macrophages, neurons and endometrium during pregnancy. According to literature, certain pathological conditions can have increased expression of TRAcP. These include patients with leukemic reticuloendotheliosis (hairy cell leukemia), Gaucher’s disease, HIV-induced encephalopathy, osteoclastoma and in osteoporosis and metabolic bone diseases."}]}]}

Presentation

Five slides of TRAcP positive tissues, each mounted on Hydrophilic Plus Slides, provided in a plastic mailer.

Principle of Procedure

Control slides are Hydrophilic Plus Slides with formalin-fixed, paraffin-embedded (FFPE) tissue or cell sections mounted on them, serving as a tool to qualitatively verify the performance of immunohistochemical staining